RGEN Q2 2019 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q2 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$71M+48.1% YoY

Gross Profit

$40M56.6% margin

Operating Income

$11M15.6% margin

Net Income

$8M11.5% margin

EPS (Diluted)

$0.17

QoQ Revenue Growth

+16.6%

Cash Flow

Operating Cash Flow

$18M

Free Cash Flow

$12M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$189M

Stockholders' Equity

$879M

Cash & Equivalents

$209M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$71M	$48M	+48.1%
Gross Profit	$40M	$27M	+50.1%
Operating Income	$11M	$4M	+158.7%
Net Income	$8M	$3M	+195.7%

Revenue Segments

Product

$71M100%

Royalty

$22,0000%